Secretive 鈥楻ebate Trap鈥 Keeps Generic Drugs For Diabetes And Other Ills Out Of Reach
Patients are often forced into using brand names because drug formularies favor them over cheaper competitors.
Drugs
861 - 880 of 1,306 Results
-
-
Podcast: KHN’s ‘What The Health?’ Drug Prices Are Rising Again. Is Someone Going To Do Something About It?
As drugmakers hike prices, interest to rein them in grows on Capitol Hill. Next week marks the anniversary of Roe v. Wade, the Supreme Court鈥檚 abortion decision, and both the House, whose leaders back abortion rights, and the Senate, controlled by abortion foes, are holding statement votes. And the government shutdown is still affecting health programs. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss these issues.
-
Meth鈥檚 Resurgence Spotlights Lack Of Meds To Combat The Addiction
While headlines continue to focus on the nation鈥檚 opioid crisis, a growing toll of overdoses and deaths related to methamphetamine use suggests this drug is making an under-the-radar comeback.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Bills, Bills, Bills: Readers And Tweeters Offer Solace, Solutions And Scoldings
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
Emergency Medical Responders Confront Racial Bias
In a recent study of patients treated by emergency medical responders in Oregon, black patients were 40 percent less likely to get pain medicine than their white peers. Why?
-
Extreme Temperatures May Pose Risks To Some Mail-Order Meds
Loretta Boesing is on a mission to make sure prescription drugs delivered by mail are safe and effective. The life of her son 鈥 and others who order medicine by mail 鈥 could depend on it, she says.
-
Health Care Industry Spends $30B A Year Pushing Its Wares, From Drugs To Stem Cell Treatment
Critics say patients are often misled by ads that advocate high-priced drugs or genetic tests.
By Liz Szabo -
Will I Always Face The Threat Of A Peanut-Laden Kiss Of Death?
A reporter with a serious peanut allergy explains what it is like to process news reports that tout new pharmaceutical products that might minimize the danger of accidental exposure.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Tainted Drugs
When Medicine Makes Patients Sicker
The Food and Drug Administration is supposed to inspect all factories, foreign and domestic, that produce drugs for the U.S. market. But a KHN review of thousands of FDA documents 鈥 inspection records, recalls, warning letters and lawsuits 鈥 reveals how drugs that are poorly manufactured or contaminated can reach consumers.
-
Medicaid Patients In Puerto Rico Don鈥檛 Get Coverage For Drugs To Cure Hepatitis C
The program that provides health care for about half of the U.S. territory鈥檚 population cannot afford to cover the drugs.
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 Ask Us Anything!
From Medicare dental coverage to drug prices to fetal tissue research, the panelists answer listeners鈥 questions. Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post join KHN鈥檚 Julie Rovner.
-
How Sen. Orrin Hatch Changed America’s Health Care
Utah's Orrin Hatch is leaving the Senate, after 42 years. The Republican led bipartisan efforts to provide health care to more kids and AIDS patients. He also thrived on donations from the drug industry.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 More On That Texas Lawsuit, And The Best And Worst Health Policy Stories Of The Year
The fallout continues from that Texas court decision that ruled Congress鈥 2017 elimination of the tax penalty for failing to have insurance rendered the entire Affordable Care Act unconstitutional. Meanwhile, enrollment for 2019 at healthcare.gov was down, but far less than many predicted. KHN鈥檚 Julie Rovner, along with panelists Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of the Washington Examiner, discuss this, plus the best, most overhyped and nerdiest stories of 2018. Also, Rovner interviews GOP strategist and pollster Frank Luntz.
-
Why The U.S. Remains The World’s Most Expensive Market For 鈥楤iologic鈥 Drugs
Biologic drugs, made from living organisms, are big moneymakers partly because they have little competition from 鈥渂iosimilars.鈥 It鈥檚 a very different story in Europe.
-
Health Care Industry 鈥楶ays Tribute鈥 To California鈥檚 Influential Lawmakers
The leaders of California鈥檚 legislative health committees who wield power over state health policy have been showered with money from the health care sector, with drug companies, health plans, hospitals and doctors providing nearly 40 percent of their 2017-18 campaign funds.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Nurse Denied Life Insurance Because She Carries Naloxone
The U.S. surgeon general has called on "bystanders" to be equipped with the opioid reversal drug to save lives. But when a nurse answered that call, her application for life insurance was denied. Why?